SEC Form 4 · accession 0001209191-16-135078
SYNAPTICS Inc · SYNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ritu Favre
Officer — See Remarks
Period of report
Jul 29, 2016
Accepted (ET)
Aug 2, 2016 · 7:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000817720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2016 | F | 500 | $57.20 | D | 12,360 | D | |
| Common Stock | Aug 1, 2016 | S | 2,426 | $51.78 | D | 9,934 | D | |
| Common Stock | Aug 2, 2016 | S | 833 | $56.92 | D | 9,101 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $51.95 | Jul 29, 2016 | A | 3,475 | A | — | Jul 29, 2023 | Common Stock | 3,475 | 3,475 | D |
Explanation of responses
- F1Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units.
- F2The shares were sold pursuant to a 10b5-1 Trading Plan dated May 17, 2016.
- F31/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the July 29, 2016 date of grant, until fully vested on July 29, 2019.
Remarks
The reporting person is the Senior Vice President and General Manager of Biometrics Product Division (BPD).